Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of ($0.01), versus $0.00 reported last year. Revenue for the quarter came in at $56.89 million, versus $45.87 million reported last year.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.